BackVenus Concept Overview

Venus Concept Receivables

Latest receivables for VERO: $17M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$16.50M
21.79% YoYΔ $-4.60M vs prior year quarter

Peer average

Loading

Venus Concept Receivables History

Loading

Venus Concept vs. peers: Receivables Comparison

Loading

Venus Concept Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Venus Concept (VERO) FAQ

As of the most recent data (September 2025), VERO shows a receivables of $17M. That compares with $21M in the prior-year period — down 21.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VERO's receivables is now $17M (was $21M) — a 21.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Venus Concept is outperforming or lagging.

Tracking VERO's receivables over time shows whether Venus Concept is scaling, shrinking, or reshaping that part of the business. The current reading is $17M That compares with $21M in the prior-year period — down 21.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Venus Concept's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $17M) with ownership activity and broader fundamentals.

Venus Concept's receivables is $17M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.